Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | January 4, 2006 |
| Target | Cytovia |
| Sector | Life Science |
| Buyer(s) | EpiCept |
| Sellers(s) | Maxim Pharmaceuticals |
| Deal Type | Divestiture |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1993 |
| Sector | Medical Products |
| Employees | 4 |
EpiCept Corporation, a specialty pharmaceutical company, focuses on the clinical development and commercialization of pharmaceutical products for the treatment of pain and cancer.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| State: California | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2006 | 1 of 1 |
Maxim Pharmaceuticals, Inc., a biopharmaceutical company, develops cancer therapeutics.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| State: California | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2006 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2000-06-16 |
Cytovia
Irvine, California, United States Commercializes a patented drug screening technology through partnerships with large pharmaceutical companies and clinical testing service companies. Cytovia was acquired by Maxim Pharmaceuticals, Inc. in June 2000. |
Buy | - |
